Annual Gross Profit
$120.80 M
-$22.62 M-15.77%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual gross profit is currently $120.80 million, with the most recent change of -$22.62 million (-15.77%) on 31 December 2023. During the last 3 years, it has fallen by -$12.34 million (-9.27%). LGND annual gross profit is now -50.72% below its all-time high of $245.12 million, reached on 31 December 2018.LGND Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$49.36 M
+$10.74 M+27.80%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly gross profit is currently $49.36 million, with the most recent change of +$10.74 million (+27.80%) on 30 September 2024. Over the past year, it has increased by +$19.98 million (+68.00%). LGND quarterly gross profit is now -44.48% below its all-time high of $88.91 million, reached on 30 June 2018.LGND Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$142.54 M
+$19.98 M+16.30%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated TTM gross profit is currently $142.54 million, with the most recent change of +$19.98 million (+16.30%) on 30 September 2024. Over the past year, it has increased by +$19.43 million (+15.79%). LGND TTM gross profit is now -41.85% below its all-time high of $245.12 million, reached on 31 December 2018.LGND TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.8% | +68.0% | +15.8% |
| 3 y3 years | -9.3% | -7.5% | -24.9% |
| 5 y5 years | -50.7% | +127.9% | +1.4% |
LGND Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.6% | at low | -7.5% | +99.9% | -24.9% | +31.2% |
| 5 y | 5 years | -50.7% | +10.9% | -8.7% | +127.9% | -24.9% | +45.8% |
| alltime | all time | -50.7% | +1159.7% | -44.5% | +920.0% | -41.9% | +1350.4% |
Ligand Pharmaceuticals Incorporated Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $49.36 M(+27.8%) | $142.54 M(+16.3%) |
| June 2024 | - | $38.63 M(+37.5%) | $122.56 M(+12.8%) |
| Mar 2024 | - | $28.10 M(+6.2%) | $108.64 M(-10.1%) |
| Dec 2023 | $120.80 M(-15.8%) | $26.46 M(-9.9%) | $120.80 M(-1.9%) |
| Sept 2023 | - | $29.38 M(+19.0%) | $123.11 M(-11.3%) |
| June 2023 | - | $24.70 M(-38.7%) | $138.79 M(-8.6%) |
| Mar 2023 | - | $40.26 M(+40.0%) | $151.86 M(+5.9%) |
| Dec 2022 | $143.42 M(-20.0%) | $28.77 M(-36.2%) | $143.42 M(+2.8%) |
| Sept 2022 | - | $45.07 M(+19.3%) | $139.55 M(-5.6%) |
| June 2022 | - | $37.77 M(+18.7%) | $147.87 M(-9.9%) |
| Mar 2022 | - | $31.82 M(+27.8%) | $164.19 M(-8.5%) |
| Dec 2021 | $179.37 M(+34.7%) | $24.90 M(-53.4%) | $179.37 M(-5.5%) |
| Sept 2021 | - | $53.39 M(-1.3%) | $189.86 M(+10.4%) |
| June 2021 | - | $54.08 M(+15.1%) | $171.97 M(+13.4%) |
| Mar 2021 | - | $47.00 M(+32.8%) | $151.66 M(+13.9%) |
| Dec 2020 | $133.14 M(+22.2%) | $35.39 M(-0.3%) | $133.14 M(+8.4%) |
| Sept 2020 | - | $35.49 M(+5.1%) | $122.81 M(+12.7%) |
| June 2020 | - | $33.78 M(+18.6%) | $108.98 M(+11.4%) |
| Mar 2020 | - | $28.48 M(+13.6%) | $97.79 M(-10.2%) |
| Dec 2019 | $108.94 M(-55.6%) | $25.07 M(+15.7%) | $108.94 M(-22.5%) |
| Sept 2019 | - | $21.66 M(-4.1%) | $140.50 M(-13.8%) |
| June 2019 | - | $22.58 M(-43.0%) | $163.05 M(-28.9%) |
| Mar 2019 | - | $39.63 M(-30.0%) | $229.37 M(-6.4%) |
| Dec 2018 | $245.12 M(+80.6%) | $56.63 M(+28.1%) | $245.12 M(+3.3%) |
| Sept 2018 | - | $44.20 M(-50.3%) | $237.21 M(+5.9%) |
| June 2018 | - | $88.91 M(+60.6%) | $223.99 M(+38.1%) |
| Mar 2018 | - | $55.37 M(+13.6%) | $162.18 M(+19.5%) |
| Dec 2017 | $135.74 M(+31.3%) | $48.73 M(+57.2%) | $135.73 M(+11.0%) |
| Sept 2017 | - | $30.99 M(+14.4%) | $122.30 M(+9.3%) |
| June 2017 | - | $27.09 M(-6.3%) | $111.93 M(+8.0%) |
| Mar 2017 | - | $28.93 M(-18.0%) | $103.64 M(+0.2%) |
| Dec 2016 | $103.40 M(+56.4%) | $35.29 M(+71.1%) | $103.40 M(+16.9%) |
| Sept 2016 | - | $20.62 M(+9.7%) | $88.42 M(+4.9%) |
| June 2016 | - | $18.80 M(-34.5%) | $84.25 M(+3.7%) |
| Mar 2016 | - | $28.69 M(+41.3%) | $81.27 M(+22.9%) |
| Dec 2015 | $66.11 M(+19.3%) | $20.31 M(+23.4%) | $66.11 M(+2.0%) |
| Sept 2015 | - | $16.45 M(+4.0%) | $64.79 M(+4.8%) |
| June 2015 | - | $15.82 M(+16.9%) | $61.82 M(+11.5%) |
| Mar 2015 | - | $13.53 M(-28.8%) | $55.42 M(+0.0%) |
| Dec 2014 | $55.40 M(+28.1%) | $19.00 M(+41.0%) | $55.40 M(+11.2%) |
| Sept 2014 | - | $13.48 M(+43.0%) | $49.83 M(+6.4%) |
| June 2014 | - | $9.42 M(-30.2%) | $46.82 M(+2.3%) |
| Mar 2014 | - | $13.51 M(+0.6%) | $45.76 M(+5.8%) |
| Dec 2013 | $43.24 M(+55.6%) | $13.42 M(+28.2%) | $43.24 M(+5.1%) |
| Sept 2013 | - | $10.47 M(+25.1%) | $41.13 M(+13.1%) |
| June 2013 | - | $8.37 M(-23.9%) | $36.35 M(+9.2%) |
| Mar 2013 | - | $10.99 M(-2.8%) | $33.29 M(+19.8%) |
| Dec 2012 | $27.79 M(+10.6%) | $11.31 M(+98.6%) | $27.79 M(+1.6%) |
| Sept 2012 | - | $5.69 M(+7.3%) | $27.36 M(+2.4%) |
| June 2012 | - | $5.31 M(-3.2%) | $26.70 M(-2.0%) |
| Mar 2012 | - | $5.48 M(-49.6%) | $27.24 M(+8.4%) |
| Dec 2011 | $25.13 M(+6.8%) | $10.88 M(+115.9%) | $25.13 M(+38.1%) |
| Sept 2011 | - | $5.04 M(-13.7%) | $18.19 M(-13.2%) |
| June 2011 | - | $5.84 M(+73.2%) | $20.95 M(+0.0%) |
| Mar 2011 | - | $3.37 M(-14.4%) | $20.95 M(-11.0%) |
| Dec 2010 | $23.54 M | $3.94 M(-49.5%) | $23.54 M(-29.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | $7.80 M(+33.6%) | $33.58 M(-0.3%) |
| June 2010 | - | $5.84 M(-2.0%) | $33.67 M(-5.0%) |
| Mar 2010 | - | $5.96 M(-57.4%) | $35.43 M(-9.0%) |
| Dec 2009 | $38.94 M(+42.6%) | $13.98 M(+76.9%) | $38.94 M(+56.0%) |
| Sept 2009 | - | $7.90 M(+4.0%) | $24.96 M(+46.3%) |
| June 2009 | - | $7.59 M(-19.8%) | $17.06 M(+80.2%) |
| Mar 2009 | - | $9.47 M(+94.3%) | $9.47 M(+94.3%) |
| Dec 2008 | $27.32 M(+111.8%) | - | - |
| Mar 2008 | - | $4.87 M(-80.9%) | $4.87 M(-95.6%) |
| Dec 2007 | $12.89 M(-86.3%) | - | - |
| Sept 2005 | - | $25.58 M(-27.2%) | $111.10 M(+3.2%) |
| June 2005 | - | $35.13 M(+35.5%) | $107.64 M(+13.2%) |
| Mar 2005 | - | $25.92 M(+5.9%) | $95.06 M(-20.1%) |
| Dec 2004 | $93.85 M(+72.0%) | $24.47 M(+10.6%) | $119.01 M(+34.4%) |
| Sept 2004 | - | $22.11 M(-2.0%) | $88.52 M(-0.7%) |
| June 2004 | - | $22.56 M(-54.8%) | $89.12 M(+1.4%) |
| Mar 2004 | - | $49.87 M(-928.4%) | $87.93 M(+61.2%) |
| Dec 2003 | $54.56 M(-4.3%) | -$6.02 M(-126.5%) | $54.56 M(-13.5%) |
| Sept 2003 | - | $22.72 M(+6.4%) | $63.08 M(+5.2%) |
| June 2003 | - | $21.36 M(+29.4%) | $59.98 M(+12.9%) |
| Mar 2003 | - | $16.50 M(+559.9%) | $53.11 M(-6.9%) |
| Dec 2002 | $57.03 M(-8.6%) | $2.50 M(-87.3%) | $57.03 M(-21.6%) |
| Sept 2002 | - | $19.62 M(+35.5%) | $72.79 M(+6.0%) |
| June 2002 | - | $14.48 M(-29.1%) | $68.70 M(-1.2%) |
| Mar 2002 | - | $20.43 M(+11.9%) | $69.56 M(+8.2%) |
| Dec 2001 | $62.39 M(+57.9%) | $18.26 M(+17.6%) | $64.27 M(+11.6%) |
| Sept 2001 | - | $15.53 M(+1.2%) | $57.58 M(+7.8%) |
| June 2001 | - | $15.35 M(+1.4%) | $53.40 M(+5.0%) |
| Mar 2001 | - | $15.13 M(+30.8%) | $50.84 M(+11.6%) |
| Dec 2000 | $39.52 M(+30.0%) | $11.57 M(+1.9%) | $45.54 M(+35.9%) |
| Sept 2000 | - | $11.35 M(-11.2%) | $33.51 M(+2.1%) |
| June 2000 | - | $12.79 M(+30.1%) | $32.83 M(+11.5%) |
| Mar 2000 | - | $9.83 M(-2233.0%) | $29.44 M(-3.2%) |
| Dec 1999 | $30.41 M(+37.0%) | -$461.00 K(-104.3%) | $30.40 M(-11.3%) |
| Sept 1999 | - | $10.66 M(+13.5%) | $34.27 M(+16.9%) |
| June 1999 | - | $9.40 M(-13.0%) | $29.30 M(+12.3%) |
| Mar 1999 | - | $10.80 M(+217.6%) | $26.10 M(+17.6%) |
| Dec 1998 | $22.20 M(-63.9%) | $3.40 M(-40.4%) | $22.20 M(-48.7%) |
| Sept 1998 | - | $5.70 M(-8.1%) | $43.30 M(-13.9%) |
| June 1998 | - | $6.20 M(-10.1%) | $50.30 M(-10.7%) |
| Mar 1998 | - | $6.90 M(-71.8%) | $56.30 M(-8.5%) |
| Dec 1997 | $61.50 M(+33.1%) | $24.50 M(+92.9%) | $61.50 M(+25.3%) |
| Sept 1997 | - | $12.70 M(+4.1%) | $49.10 M(-3.9%) |
| June 1997 | - | $12.20 M(+0.8%) | $51.10 M(+5.1%) |
| Mar 1997 | - | $12.10 M(0.0%) | $48.60 M(+4.7%) |
| Dec 1996 | $46.20 M(+63.8%) | $12.10 M(-17.7%) | $46.40 M(+6.9%) |
| Sept 1996 | - | $14.70 M(+51.5%) | $43.40 M(+19.9%) |
| June 1996 | - | $9.70 M(-2.0%) | $36.20 M(+36.6%) |
| Mar 1996 | - | $9.90 M(+8.8%) | $26.50 M(+21.0%) |
| Dec 1995 | $28.20 M(-347.4%) | $9.10 M(+21.3%) | $21.90 M(+92.1%) |
| Sept 1995 | - | $7.50 M(+41.5%) | $11.40 M(-556.0%) |
| Mar 1995 | - | $5.30 M(-478.6%) | -$2.50 M(-78.1%) |
| Dec 1994 | -$11.40 M | -$1.40 M(-48.1%) | -$11.40 M(+14.0%) |
| Sept 1994 | - | -$2.70 M(-27.0%) | -$10.00 M(+37.0%) |
| June 1994 | - | -$3.70 M(+2.8%) | -$7.30 M(+102.8%) |
| Mar 1994 | - | -$3.60 M | -$3.60 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual gross profit?
- What is the all time high annual gross profit for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual gross profit year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly gross profit?
- What is the all time high quarterly gross profit for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM gross profit?
- What is the all time high TTM gross profit for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM gross profit year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual gross profit?
The current annual gross profit of LGND is $120.80 M
What is the all time high annual gross profit for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual gross profit is $245.12 M
What is Ligand Pharmaceuticals Incorporated annual gross profit year-on-year change?
Over the past year, LGND annual gross profit has changed by -$22.62 M (-15.77%)
What is Ligand Pharmaceuticals Incorporated quarterly gross profit?
The current quarterly gross profit of LGND is $49.36 M
What is the all time high quarterly gross profit for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly gross profit is $88.91 M
What is Ligand Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
Over the past year, LGND quarterly gross profit has changed by +$19.98 M (+68.00%)
What is Ligand Pharmaceuticals Incorporated TTM gross profit?
The current TTM gross profit of LGND is $142.54 M
What is the all time high TTM gross profit for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM gross profit is $245.12 M
What is Ligand Pharmaceuticals Incorporated TTM gross profit year-on-year change?
Over the past year, LGND TTM gross profit has changed by +$19.43 M (+15.79%)